Status | Study |
NOT_YET_RECRUITING |
Study Name: Standardising Care for Hepatitis Delta in the Netherlands Condition: Date: 2023-06-06 |
Recruiting |
Study Name: Ezetimibe for Patients With Chronic Hepatitis D Condition: Chronic Hepatitis D Date: 2017-03-28 Interventions: Drug: Ezetimibe Ezetimibe 20 mg oral daily |
Active, not recruiting |
Study Name: Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D Condition: Hepatitis D, Chronic Date: 2017-03-26 Interventions: Drug: Pegylated interferon alfa |
Not yet recruiting |
Study Name: A Study of Lonafarnib With or Without Ritonavir in Patients With HDV Condition: Chronic Delta Hepatitis Date: 2016-11-15 Interventions: Drug: Lonafarnib antiviral far |
Active, not recruiting |
Study Name: A Long Term Follow-up Study of Patients From the REP 301 Protocol Condition: Hepatitis B, Chronic Hepatitis D, Chronic Date: 2016-08-16 |
Recruiting |
Study Name: A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection Condition: Hepatitis D, Chronic Date: 2016-05-05 Interventions: Drug: Lambda |
Completed |
Study Name: A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD) Condition: Hepatitis D, Chronic Date: 2016-04-05 Interventions: Drug: Pegylated Interferon (PEG-IFN) alfa-2a Participants received pegylated interferon (PEG-IFN) alfa-2 |
Completed |
Study Name: A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD) Condition: Hepatitis D, Chronic Date: 2016-04-01 Interventions: Drug: Peginterferon alfa-2a Pe |
Active, not recruiting |
Study Name: Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With Chronic Hepatitis Delta Condition: Chronic Hepatitis D Infection Date: 2015-12-17 Interventions: Drug: Myrcludex B Drug: pegINF |
Terminated |
Study Name: Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic HBV Condition: Hepatitis B Hepatitis D Date: 2015-10-14 Interventions: Drug: ARC-520 Drug: Entecavir |